Changli Wang

614 total citations
16 papers, 475 citations indexed

About

Changli Wang is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Changli Wang has authored 16 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 4 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Changli Wang's work include Inflammatory Biomarkers in Disease Prognosis (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cancer, Lipids, and Metabolism (3 papers). Changli Wang is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cancer, Lipids, and Metabolism (3 papers). Changli Wang collaborates with scholars based in China, United States and Ukraine. Changli Wang's co-authors include Lianmin Zhang, Dongsheng Yue, Bin Zhang, Bin Zhang, Liuwei Gao, Hua Zhang, Hua Zhang, Xiaoyan Sun, Xiubao Ren and Liang Liu and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Changli Wang

15 papers receiving 468 citations

Peers

Changli Wang
Suna Çokmert Türkiye
Erjiang Tang China
Katrin Hefler‐Frischmuth Austria
Xiaobo He China
Guochen Duan China
Yasemi̇n Kemal Türkiye
Tsunehiko Shigemori Japan
Jun-Zhong Lin China
David Chan Australia
Ping‐Tsung Chen Taiwan
Suna Çokmert Türkiye
Changli Wang
Citations per year, relative to Changli Wang Changli Wang (= 1×) peers Suna Çokmert

Countries citing papers authored by Changli Wang

Since Specialization
Citations

This map shows the geographic impact of Changli Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changli Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changli Wang more than expected).

Fields of papers citing papers by Changli Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changli Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changli Wang. The network helps show where Changli Wang may publish in the future.

Co-authorship network of co-authors of Changli Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Changli Wang. A scholar is included among the top collaborators of Changli Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changli Wang. Changli Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Lü, Shun, Lunxu Liu, Rui Li, et al.. (2025). Efficacy and Safety of Atezolizumab in Chinese Patients With Advanced Thymic Carcinoma: A Multicenter, Single-Arm Phase 2 Study. Clinical Lung Cancer. 26(3). 244–252.e2.
2.
Mu, Nan, Yan Li, Jintao Gu, et al.. (2025). TNF ‐α Promotes Synovial Inflammation and Cartilage Bone Destruction in Rheumatoid Arthritis via NF ‐ κB / YY1 / miR ‐103a‐3p Axis. The FASEB Journal. 39(14). e70876–e70876. 4 indexed citations
3.
Ren, Shengxiang, Jifeng Feng, Shenglin Ma, et al.. (2023). KEYNOTE‐033: Randomized phase 3 study of pembrolizumab vs docetaxel in previously treated, PD‐L1‐positive, advanced NSCLC. International Journal of Cancer. 153(3). 623–634. 12 indexed citations
4.
Wang, Changli, Ke‐Neng Chen, Qixun Chen, et al.. (2023). Abstract CT081: Neoadjuvant nivolumab (NIVO) + chemotherapy (chemo) vs chemo in Chinese patients (pts) with resectable NSCLC in CheckMate 816. Cancer Research. 83(8_Supplement). CT081–CT081. 1 indexed citations
5.
Wang, Changli, Dan Zhang, Liping Wang, et al.. (2022). Methane-rich saline protects against sepsis-associated cognitive deficits in mice. Brain Research. 1791. 148000–148000. 2 indexed citations
6.
Sun, Xiaoyan, Weiran Liu, Leina Sun, et al.. (2022). Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer. Journal for ImmunoTherapy of Cancer. 10(11). e005531–e005531. 91 indexed citations
7.
Jiang, Zhengyu, Changli Wang, Zhenzhen Zhao, et al.. (2019). Plasma metabolomics of early parenteral nutrition followed with enteral nutrition in pancreatic surgery patients. Scientific Reports. 9(1). 18846–18846. 6 indexed citations
8.
Zhang, Lianmin, Hua Zhang, Dongsheng Yue, et al.. (2019). The prognostic value of the preoperative albumin to alkaline phosphatase ratio in patients with non‐small cell lung cancer after surgery. Thoracic Cancer. 10(7). 1581–1589. 18 indexed citations
9.
Ma, Yuchen, Hua Zhang, Bin Zhang, & Changli Wang. (2018). Prognostic value of pretreatment platelet and fibrinogen levels for early non-small cell lung cancer after complete resection. Clinical Oncology and Cancer Research. 45(5). 222–227. 1 indexed citations
10.
Zhang, Hua, Bin Zhang, Liuwei Gao, et al.. (2018). Preoperative albumin‐to‐globulin ratio predicts survival in patients with non‐small‐cell lung cancer after surgery. Journal of Cellular Physiology. 234(3). 2471–2479. 33 indexed citations
11.
Gao, Liuwei, Hua Zhang, Bin Zhang, Lianmin Zhang, & Changli Wang. (2017). Prognostic value of combination of preoperative platelet count and mean platelet volume in patients with resectable non-small cell lung cancer. Oncotarget. 8(9). 15632–15641. 46 indexed citations
12.
Zhao, Peng, et al.. (2016). [Study on Deproteinization of Polysaccharides from Dioscorea nipponica].. PubMed. 39(5). 1110–3. 1 indexed citations
13.
14.
15.
Zhi, Xiuyi, Wen Gao, Baohui Han, et al.. (2013). VATS lobectomy facilitates the delivery of adjuvant docetaxel-carboplatin chemotherapy in patients with non-small cell lung cancer.. PubMed. 5(5). 578–84. 10 indexed citations
16.
Li, Runmei, Changli Wang, Liang Liu, et al.. (2012). Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study. Cancer Immunology Immunotherapy. 61(11). 2125–2133. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suna Çokmert Breakdown of academic impact, for papers by Erjiang Tang Breakdown of academic impact, for papers by Katrin Hefler‐Frischmuth Breakdown of academic impact, for papers by Xiaobo He Breakdown of academic impact, for papers by Guochen Duan Breakdown of academic impact, for papers by Yasemi̇n Kemal Breakdown of academic impact, for papers by Tsunehiko Shigemori Breakdown of academic impact, for papers by Jun-Zhong Lin Breakdown of academic impact, for papers by David Chan Breakdown of academic impact, for papers by Ping‐Tsung Chen
Rankless by CCL
2026